company background image
TEVJ.F logo

Teva Pharmaceutical Industries OTCPK:TEVJ.F Stock Report

Last Price

US$14.00

Market Cap

US$16.2b

7D

6.1%

1Y

77.0%

Updated

27 Mar, 2024

Data

Company Financials +

Teva Pharmaceutical Industries Limited

OTCPK:TEVJ.F Stock Report

Market Cap: US$16.2b

TEVJ.F Stock Overview

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally.

TEVJ.F fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Teva Pharmaceutical Industries Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Teva Pharmaceutical Industries
Historical stock prices
Current Share PriceUS$14.00
52 Week HighUS$14.00
52 Week LowUS$7.03
Beta1.04
1 Month Change13.18%
3 Month Changen/a
1 Year Change76.99%
3 Year Change20.27%
5 Year Changen/a
Change since IPO-74.45%

Recent News & Updates

Recent updates

Shareholder Returns

TEVJ.FUS PharmaceuticalsUS Market
7D6.1%-0.2%0.6%
1Y77.0%23.9%29.5%

Return vs Industry: TEVJ.F exceeded the US Pharmaceuticals industry which returned 23.9% over the past year.

Return vs Market: TEVJ.F exceeded the US Market which returned 29.5% over the past year.

Price Volatility

Is TEVJ.F's price volatile compared to industry and market?
TEVJ.F volatility
TEVJ.F Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: TEVJ.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine TEVJ.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
190135,737Richard Francishttps://www.tevapharm.com

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas.

Teva Pharmaceutical Industries Limited Fundamentals Summary

How do Teva Pharmaceutical Industries's earnings and revenue compare to its market cap?
TEVJ.F fundamental statistics
Market capUS$16.18b
Earnings (TTM)-US$559.00m
Revenue (TTM)US$15.85b

1.0x

P/S Ratio

-28.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TEVJ.F income statement (TTM)
RevenueUS$15.85b
Cost of RevenueUS$8.20b
Gross ProfitUS$7.65b
Other ExpensesUS$8.21b
Earnings-US$559.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.50
Gross Margin48.25%
Net Profit Margin-3.53%
Debt/Equity Ratio244.1%

How did TEVJ.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.